Your browser doesn't support javascript.
loading
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.
Shields, Adrian M; Faustini, Sian E; Hill, Harriet J; Al-Taei, Saly; Tanner, Chloe; Ashford, Fiona; Workman, Sarita; Moreira, Fernando; Verma, Nisha; Wagg, Hollie; Heritage, Gail; Campton, Naomi; Stamataki, Zania; Drayson, Mark T; Klenerman, Paul; Thaventhiran, James E D; Elkhalifa, Shuayb; Goddard, Sarah; Johnston, Sarah; Huissoon, Aarnoud; Bethune, Claire; Elcombe, Suzanne; Lowe, David M; Patel, Smita Y; Savic, Sinisa; Richter, Alex G; Burns, Siobhan O.
Afiliación
  • Shields AM; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Faustini SE; Department of Clinical Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Hill HJ; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Al-Taei S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Tanner C; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Ashford F; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Workman S; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Moreira F; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Verma N; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Wagg H; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Heritage G; Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom.
  • Campton N; Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom.
  • Stamataki Z; Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom.
  • Drayson MT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Klenerman P; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Thaventhiran JED; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Elkhalifa S; Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Goddard S; Department of Immunology, Salford Royal NHS Foundation Trust, Salford, United Kingdom.
  • Johnston S; Department of Clinical Immunology, University Hospitals North Midlands, Stoke-on-Trent, United Kingdom.
  • Huissoon A; Department of Clinical Immunology, North Bristol NHS Trust, Bristol, United Kingdom.
  • Bethune C; Department of Clinical Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Elcombe S; Department of Allergy and Clinical Immunology, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
  • Lowe DM; Department of Allergy and Clinical Immunology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
  • Patel SY; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Savic S; Institute of Immunity and Transplantation, University College London, London, United Kingdom.
  • Richter AG; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Burns SO; National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) Oxford Biomedical Centre, University of Oxford, Oxford, United Kingdom.
Front Immunol ; 13: 912571, 2022.
Article en En | MEDLINE | ID: mdl-35720400
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido